Immunohistochemical detection of p53 and BcI-2 in colorectal carcinoma: no evidence for prognostic significance
1998

Prognostic Significance of p53 and Bcl-2 in Colorectal Cancer

Sample size: 238 publication Evidence: low

Author Information

Author(s): RAEM Tollenaar, JHJM van Krieken, H-J van Slooten, DJ Bruinvels, KMJ Nelemans, LJ van den Broek, J Hermans, JH van Dierendonck

Primary Institution: Leiden University Medical Center

Hypothesis

The study evaluates the prognostic significance of p53 and Bcl-2 proteins in colorectal cancer.

Conclusion

The study found that immunohistochemical detection of p53 and Bcl-2 does not provide relevant prognostic information for colorectal cancer patients.

Supporting Evidence

  • 35% of carcinomas showed no nuclear staining for p53.
  • 51% of tumors were completely negative for Bcl-2.
  • An association was found between nuclear p53 accumulation and mucinous tumors.

Takeaway

The study looked at two proteins in colorectal cancer to see if they could help predict how patients would do, but they didn't find any useful information.

Methodology

The study analyzed tissue sections from 238 colorectal carcinomas using immunohistochemistry to assess p53 and Bcl-2 expression.

Limitations

The study did not find significant correlations between p53 or Bcl-2 expression and clinicopathological parameters or patient survival.

Participant Demographics

Patients who underwent curative resection for colorectal adenocarcinoma without adjuvant chemotherapy.

Statistical Information

P-Value

0.01

Statistical Significance

p=0.01

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication